Evaluation of the blood kinetics of collagen peptide metabolites by ingestion of collagen peptides with different formulations

Evaluation of the blood kinetics of collagen peptide metabolites by ingestion of collagen peptides with different formulations - Evaluation of the blood kinetics of collagen peptide metabolites by ingestion of collagen peptides with different formulations

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000051074

Enrollment

Registered

2023-05-22

Start date

2022-12-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

To ingest HACP-TFC To ingest CPF-C To ingest Meta Collagen

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1) Japanese males aged 20 to 59 years old??at the time of informed consent 2) Subjects whose height is between 160 and 178 cm 3) Subjects whose BMI is between 22 and 25

Exclusion criteria

Exclusion criteria: 1) Subjects with severe gastrointestinal, hepatic, renal, circulatory, hematologic, endocrine, or malignant neoplasm suspected or with a history of such diseases 2) Subjects who have possibility of allergy to gelatine

Design outcomes

Primary

Measure	Time frame
blood concentraion of collagen peptide metabolites before and 5, 10, 15, 30, 60 minutes after ingestion of test foods	—

Countries

Japan

Contacts

Public ContactYuki Nagai

SOUKEN Co., Ltd Management Division

y_nagai@mail.souken-r.com03-5408-1555

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026